Absci Corp reports results for the quarter ended September 30 - Earnings Summary

* Absci Corp  ABSI.OQ  reported a quarterly adjusted loss
of 24
cents​​ per share for the quarter ended September 30, identical
to the same quarter last year.  The mean expectation of
seven analysts for the quarter was for a loss of 21 cents per
share. Wall Street expected results to range from -25 cents
to -18 cents per share.
    * Revenue rose 128.6% to $1.70 million from a year ago;
analysts
expected $1.75 million. 
    * Absci Corp's reported EPS for the quarter was a loss of 24
cents​.
    * The company reported a quarterly loss of $27.4 million.
    * Absci Corp shares had risen by 12.0% this quarter and
gained 1.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 4.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Absci Corp is
7.00 
This summary was machine generated from LSEG data November 12 at
03:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.21          -0.24          Missed
 Jun. 30 2024      -0.19          -0.22          Missed
 Mar. 31 2024      -0.21          -0.22          Missed
 Dec. 31 2023      -0.25          -0.25          Met

Recent news on AbSci

See all news